The introduction of new interventional treatment options such as atherectomy drives the market growth. Atherectomy is beneficial in removing the build-up of plaque in arteries with the help of stent or catheter. Thus, with the increase in prevalence of calcified and hard lesions the market for atherectomy is expected to grow.
The major market players are analyzed in the Peripheral Artery Disease Market report including Abbott Laboratories, Cook Medical, C. R. Bard, Inc., Terumo Corporation, AngioDynamics, Inc., B. Braun Melsungen AG, Boston Scientific Corporation, Cardinal Health, Inc., Medtronic plc, The Spectranetics Corporation, and BIOTRONIK.
According to the report, the global peripheral artery disease market was pegged at $3.14 billion in 2016 and is expected to garner $4.98 billion by 2023, registering a CAGR of 6.8% during the period from 2017 to 2023.
Rise in prevalence of chronic diseases, advent of advanced interventional products, improved insurance and reimbursement, and improvement of healthcare infrastructure in developing countries have boosted the growth of the global peripheral artery disease market. However, stringent approval process for stents hampers market growth. On the contrary, untapped markets in developing countries are expected to create lucrative opportunities in the near future.
Download Sample of the Report @ https://www.alliedmarketresearch.com/request-sample/4315
The market is divided on the basis of type and geography. Based on the type, the market is bifurcated into peripheral angioplasty balloons, peripheral stents, peripheral catheters, inferior vena cava (IVC) filters, plaque modification devices, hemodynamic flow alteration devices, and peripheral accessories. The peripheral stents segment held the largest share in the market as it reduced the risks associated with the build-up of plaque in the arteries. However, the plaque modification devices segment is projected to register the fastest CAGR of 7.6% through 2023.
Based on geography, the market is divided into North America, Asia-Pacific, Europe, and LAMEA. the Asia-Pacific region is estimated to portray the fastest growth with a CAGR of 7.9% during the study period, owing to the rise in a number of patients suffering from obesity, diabetes, and high blood pressure.
Buy Now @ https://www.alliedmarketresearch.com/checkout/448702
About us
Allied Market Research, a market research and advisory company of Allied Analytics LLP,
provides business insights and market research reports to large as well as small &
medium enterprises. The company assists its clients to strategize business policies and
achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection
to investment advice. The analysts at Allied Market Research dig out factors that help
clients to understand the significance and impact of market dynamics. The company
amplies client’s insight on the factors, such as strategies, future estimations, growth
or fall forecasting, opportunity analysis, and consumer surveys among others. As
follows, the company offers consistent business intelligent support to aid the clients
to turn into prominent business firm.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com
Your information will never be shared with any third party.